{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T13:29:49Z","timestamp":1772198989884,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2011,9,16]],"date-time":"2011-09-16T00:00:00Z","timestamp":1316131200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Surg Today"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s00595-010-4519-2","type":"journal-article","created":{"date-parts":[[2011,9,15]],"date-time":"2011-09-15T14:44:55Z","timestamp":1316097895000},"page":"1357-1362","source":"Crossref","is-referenced-by-count":11,"title":["Accuracy of monitoring serum carcinoembryonic antigen levels in postoperative stage III colorectal cancer patients is limited to only the first postoperative year"],"prefix":"10.1007","volume":"41","author":[{"given":"Masayasu","family":"Hara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikinori","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Takayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromitsu","family":"Takeyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,9,16]]},"reference":[{"key":"4519_CR1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s003840050188","volume":"13","author":"T.A. Rockall","year":"1999","unstructured":"Rockall TA, McDonald PJ. Carcinoembryonic antigen: its value in the follow-up of patients with colorectal cancer. Int J Colorectal Dis 1999;13:73\u201377.","journal-title":"Int J Colorectal Dis"},{"key":"4519_CR2","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/0014-2964(80)90259-5","volume":"16","author":"G. Mariani","year":"1980","unstructured":"Mariani G, Carmellini M, Bonaguidi F, Benelli MA, Toni MG. Serum CEA monitoring in the follow-up of colorectal cancer patients with negative preoperative serum CEA. Eur J Cancer 1980;16:1099\u20131103.","journal-title":"Eur J Cancer"},{"key":"4519_CR3","doi-asserted-by":"crossref","first-page":"8512","DOI":"10.1200\/JCO.2005.04.0063","volume":"23","author":"C.E. Desch","year":"2005","unstructured":"Desch CE, Benson AB 3rd, Somerfield MR, Flynn PJ, Krause C, Loprinzi CL, et al. Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol 2005;23:8512\u20138519.","journal-title":"J Clin Oncol"},{"key":"4519_CR4","doi-asserted-by":"crossref","first-page":"5313","DOI":"10.1200\/JCO.2006.08.2644","volume":"24","author":"G.Y. Locker","year":"2006","unstructured":"Locker GY, Hamilton S, Harris J, Jessup JM, Kemeny N, Macdonald JS, et al. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol 2006;24:5313\u20135327.","journal-title":"J Clin Oncol"},{"key":"4519_CR5","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/annonc\/mdg297","volume":"14","author":"K.M. Tveit","year":"2003","unstructured":"Tveit KM. ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of rectal cancer. Ann Oncol 2003;14:1006\u20131007.","journal-title":"Ann Oncol"},{"key":"4519_CR6","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S0959-8049(02)00811-0","volume":"39","author":"M.J. Duffy","year":"2003","unstructured":"Duffy MJ, van Dalen A, Haglund C, Hansson L, Klapdor R, Lamerz R, et al. Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines. Eur J Cancer 2003;39:718\u2013727.","journal-title":"Eur J Cancer"},{"key":"4519_CR7","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/(SICI)1096-9098(199712)66:4<238::AID-JSO3>3.0.CO;2-C","volume":"66","author":"T. Nakayama","year":"1997","unstructured":"Nakayama T, Watanabe M, Teramoto T, Kitajima M. CA19-9 as a predictor of recurrence in patients with colorectal cancer. J Surg Oncol 1997;66:238\u2013243.","journal-title":"J Surg Oncol"},{"key":"4519_CR8","first-page":"5195","volume":"20","author":"W. Reiter","year":"2000","unstructured":"Reiter W, Stieber P, Reuter C, Nagel D, Lau-Werner U, Lamerz R. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer. Anticancer Res 2000;20:5195\u20135198.","journal-title":"Anticancer Res"},{"key":"4519_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000217867","volume":"15","author":"X. Filella","year":"1994","unstructured":"Filella X, Molina R, Pique JM, Garcia-Valdecasas JC, Grau JJ, Novell F, et al. Use of CA 19-9 in the early detection of recurrences in colorectal cancer: comparison with CEA. Tumour Biol 1994;15:1\u20136.","journal-title":"Tumour Biol"},{"key":"4519_CR10","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.ejca.2007.03.021","volume":"43","author":"M.J. Duffy","year":"2007","unstructured":"Duffy MJ, van Dalen A, Haglund C, Hansson L, Holinski-Feder E, Klapdor R, et al. Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use. Eur J Cancer 2007;43:1348\u20131360.","journal-title":"Eur J Cancer"},{"key":"4519_CR11","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/clinchem\/47.4.624","volume":"47","author":"M.J. Duffy","year":"2001","unstructured":"Duffy MJ. Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful? Clin Chem 2001;47:624\u2013630.","journal-title":"Clin Chem"},{"key":"4519_CR12","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1245\/s10434-006-9060-6","volume":"14","author":"H. Korner","year":"2007","unstructured":"Korner H, Soreide K, Stokkeland PJ, Soreide JA. Diagnostic accuracy of serum-carcinoembryonic antigen in recurrent colorectal cancer: a receiver operating characteristic curve analysis. Ann Surg Oncol 2007;14:417\u2013423.","journal-title":"Ann Surg Oncol"},{"key":"4519_CR13","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00268-005-7913-y","volume":"29","author":"M. Bhandari","year":"2005","unstructured":"Bhandari M, Guyatt GH. How to appraise a diagnostic test. World J Surg 2005;29:561\u2013566.","journal-title":"World J Surg"},{"key":"4519_CR14","first-page":"4953","volume":"20","author":"M.W. Wichmann","year":"2000","unstructured":"Wichmann MW, Lau-Werner U, Muller C, Hornung HM, Stieber P, Schildberg FW. Carcinoembryonic antigen for the detection of recurrent disease following curative resection of colorectal cancer. Anticancer Res 2000;20:4953\u20134955.","journal-title":"Anticancer Res"},{"key":"4519_CR15","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.3748\/wjg.v12.i24.3891","volume":"12","author":"L.C. Fernandes","year":"2006","unstructured":"Fernandes LC, Kim SB, Saad SS, Matos D. Value of carcinoembryonic antigen and cytokeratins for the detection of recurrent disease following curative resection of colorectal cancer. World J Gastroenterol 2006;12:3891\u20133894.","journal-title":"World J Gastroenterol"},{"key":"4519_CR16","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0748-7983(97)93045-6","volume":"23","author":"L. Salvo De","year":"1997","unstructured":"De Salvo L, Razzetta F, Arezzo A, Tassone U, Bogliolo G, Bruzzone D, et al. Surveillance after colorectal cancer surgery. Eur J Surg Oncol 1997;23:522\u2013525.","journal-title":"Eur J Surg Oncol"},{"key":"4519_CR17","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1001\/jama.239.11.1065","volume":"239","author":"C.G. Moertel","year":"1978","unstructured":"Moertel CG, Schutt AJ, Go VL. Carcinoembryonic antigen test for recurrent colorectal carcinoma. Inadequacy for early detection. JAMA 1978;239:1065\u20131066.","journal-title":"JAMA"},{"key":"4519_CR18","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1200\/JCO.1996.14.10.2843","volume":"14","author":"Clinical practice guidelines for the use of tumor markers in breastcolorectal cancer.","year":"1996","unstructured":"Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. Adopted on May 17, 1996 by the American Society of Clinical Oncology. J Clin Oncol 1996;14:2843\u20132877.","journal-title":"J Clin Oncol"},{"key":"4519_CR19","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1007\/s10350-008-9406-1","volume":"11","author":"M. Hara","year":"2008","unstructured":"Hara M, Kanemitsu Y, Hirai T, Komori K, Kato T. Negative serum carcinoembryonic antigen has insufficient accuracy for excluding recurrence from patients with Dukes C colorectal cancer: analysis with likelihood ratio and posttest probability in a follow-up study. Dis Colon Rectum 2008;11:1675\u20131680.","journal-title":"Dis Colon Rectum"},{"key":"4519_CR20","volume-title":"Evidence-based medicine: how to practice and teach EBM","author":"D.L. Sackett","year":"2000","unstructured":"Sackett DL, Strauss SE, Richardson WS. Evidence-based medicine: how to practice and teach EBM. New York: Churchill Livingstone; 2000."},{"key":"4519_CR21","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1651-2227.2006.00179.x","volume":"96","author":"A.K. Akobeng","year":"2007","unstructured":"Akobeng AK. Understanding diagnostic tests 2: likelihood ratios, pre- and post-test probabilities and their use in clinical practice. Acta Paediatr 2007;96:487\u2013491.","journal-title":"Acta Paediatr"},{"key":"4519_CR22","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0004-9514(14)60228-2","volume":"48","author":"M. Davidson","year":"2002","unstructured":"Davidson M. The interpretation of diagnostic test: a primer for physiotherapists. Aust J Physiother 2002;48:227\u2013232.","journal-title":"Aust J Physiother"},{"key":"4519_CR23","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/0002-9610(78)90028-4","volume":"135","author":"J.P. Welch","year":"1978","unstructured":"Welch JP, Donaldson GA. Detection and treatment of recurrent cancer of the colon and rectum. Am J Surg 1978;135:505\u2013511.","journal-title":"Am J Surg"},{"key":"4519_CR24","first-page":"1362","volume":"50","author":"S. Sadahiro","year":"2003","unstructured":"Sadahiro S, Suzuki T, Ishikawa K, Nakamura T, Tanaka Y, Masuda T, et al. Recurrence patterns after curative resection of colorectal cancer in patients followed for a minimum of ten years. Hepatogastroenterology 2003;50:1362\u20131366.","journal-title":"Hepatogastroenterology"},{"key":"4519_CR25","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jama.270.8.943","volume":"270","author":"C.G. Moerte","year":"1993","unstructured":"Moerte, CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Tangen C. An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer JAMA 1993;270:943\u2013947.","journal-title":"JAMA"},{"key":"4519_CR26","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/BF02052591","volume":"37","author":"J.L. McCall","year":"1994","unstructured":"McCall JL, Black RB, Rich CA, Harvey JR, Baker RA, Watts J, et al. The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancer. Dis Colon Rectum 1994;37:875\u2013881.","journal-title":"Dis Colon Rectum"}],"container-title":["Surgery Today"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-010-4519-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00595-010-4519-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-010-4519-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T23:05:01Z","timestamp":1592953501000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00595-010-4519-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,16]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["4519"],"URL":"https:\/\/doi.org\/10.1007\/s00595-010-4519-2","relation":{},"ISSN":["0941-1291","1436-2813"],"issn-type":[{"value":"0941-1291","type":"print"},{"value":"1436-2813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,16]]}}}